
1. Arch Biochem Biophys. 2020 Sep 30;691:108487. doi: 10.1016/j.abb.2020.108487.
Epub 2020 Jul 22.

Adepamycin: design, synthesis and biological properties of a new peptide with
antimicrobial properties.

Almeida LHO(1), Oliveira CFR(2), Rodrigues MS(3), Neto SM(4), Boleti APA(5),
Taveira GB(6), Mello ÉO(7), Gomes VM(8), Santos ELD(9), Crusca E Jr(10), Franco
OL(11), Cardoso MHES(12), Macedo MLR(13).

Author information: 
(1)Laboratório de Purificação de Proteínas e suas Funções Biológicas,
Universidade Federal de Mato Grosso do Sul, Cidade Universitária, 79.070-900,
Campo Grande, Mato Grosso do Sul, Brazil. Electronic address:
luishenrique.oa@gmail.com.
(2)Universidade Federal da Grande Dourados, 79.804-970, Dourados, Mato Grosso do 
Sul, Brazil. Electronic address: oliveiracfr@gmail.com.
(3)Laboratório de Purificação de Proteínas e suas Funções Biológicas,
Universidade Federal de Mato Grosso do Sul, Cidade Universitária, 79.070-900,
Campo Grande, Mato Grosso do Sul, Brazil. Electronic address:
maysouza_rodrigues@hotmail.com.
(4)Laboratório de Purificação de Proteínas e suas Funções Biológicas,
Universidade Federal de Mato Grosso do Sul, Cidade Universitária, 79.070-900,
Campo Grande, Mato Grosso do Sul, Brazil. Electronic address:
simoneneto@gmail.com.
(5)Universidade Federal da Grande Dourados, 79.804-970, Dourados, Mato Grosso do 
Sul, Brazil. Electronic address: apboleti@yahoo.com.br.
(6)Laboratório de Bioquímica e Fisiologia de Microrganismos, Universidade
Estadual do Norte Fluminense Darcy Ribeiro, 28.013-602, Campo dos Goytacazes, Rio
de Janeiro, Brazil. Electronic address: gabrielbtaveira@yahoo.com.br.
(7)Laboratório de Bioquímica e Fisiologia de Microrganismos, Universidade
Estadual do Norte Fluminense Darcy Ribeiro, 28.013-602, Campo dos Goytacazes, Rio
de Janeiro, Brazil. Electronic address: ericamello08@gmail.com.
(8)Laboratório de Bioquímica e Fisiologia de Microrganismos, Universidade
Estadual do Norte Fluminense Darcy Ribeiro, 28.013-602, Campo dos Goytacazes, Rio
de Janeiro, Brazil. Electronic address: valmguenf@gmail.com.
(9)Universidade Federal da Grande Dourados, 79.804-970, Dourados, Mato Grosso do 
Sul, Brazil. Electronic address: edsonsantos@ufgd.edu.br.
(10)Universidade Estadual Paulista Júlio de Mesquita Filho, 14.800-060,
Araraquara, Sao Paulo, Brazil. Electronic address: ecrusca@gmail.com.
(11)Centro de Análises Proteômicas e Bioquímicas, Universidade Católica de
Brasília, 70.790-160, Brasília, Distrito Federal, Brazil; S-Inova Biotech,
Universidade Católica Dom Bosco, 79.117-010, Campo Grande, Mato Grosso do Sul,
Brazil. Electronic address: ocfranco@gmail.com.
(12)Centro de Análises Proteômicas e Bioquímicas, Universidade Católica de
Brasília, 70.790-160, Brasília, Distrito Federal, Brazil; S-Inova Biotech,
Universidade Católica Dom Bosco, 79.117-010, Campo Grande, Mato Grosso do Sul,
Brazil. Electronic address: marlonhenrique6@gmail.com.
(13)Laboratório de Purificação de Proteínas e suas Funções Biológicas,
Universidade Federal de Mato Grosso do Sul, Cidade Universitária, 79.070-900,
Campo Grande, Mato Grosso do Sul, Brazil. Electronic address:
ligiamacedo18@gmail.com.

Antimicrobial peptides (AMP) are molecules with a broad spectrum of activities
that have been identified in most living organisms. In addition, synthetic AMPs
designed from natural polypeptides have been largely investigated. Here, we
designed a novel AMP using the amino acid sequence of a plant trypsin inhibitor
from Adenanthera pavonina seeds (ApTI) as a template. The 176 amino acid residues
ApTI sequence was cleaved in silico using the Collection of Antimicrobial
Peptides (CAMPR3), through the sliding-window method. Further improvements in AMP
structure were carried out, resulting in adepamycin, an AMP designed from ApTI.
Adepamycin showed antimicrobial activity from 0.9 to 3.6 μM against Escherichia
coli, Klebsiella oxytoca, Klebsiella pneumoniae, Pseudomonas aeruginosa, and
Staphylococcus aureus strains. Moreover, this peptide also displayed activity
against Candida albicans and Candida tropicalis. No toxic effects were observed
on healthy human cells. Studies on the mechanism of action of adepamycin were
carried out using an E. coli and C. tropicalis. Adepamycin triggers membrane
disturbances, leading to intracellular nucleic acids release in E. coli. For C.
tropicalis, an initial interference with the plasma membrane integrity is
followed by the formation of intracellular reactive oxygen species (ROS), leading
to apoptosis. Structurally, adepamycin was submitted to circular dichroism
spectroscopy, molecular modeling and molecular dynamics simulations, revealing an
environment-dependent α-helical structure in the presence of 2,2,2-
trifluoroethanol (TFE) and in contact with mimetic vesicles/membranes. Therefore,
adepamycin represents a novel lytic AMP with dual antibacterial and antifungal
properties.

Copyright © 2020 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.abb.2020.108487 
PMID: 32710881 

